Related Experiment Video
Updated: Mar 22, 2026
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Clinical outcome measures in juvenile idiopathic arthritis
Alessandro Consolaro1,2, Gabriella Giancane3, Benedetta Schiappapietra3
1Istituto Giannina Gaslini, Genova, Italy. alessandroconsolaro@gaslini.org.
Insights
Juvenile idiopathic arthritis (JIA) management is improving with standardized disease activity measures like the Juvenile Disease Activity Score (JADAS). Incorporating patient-reported outcomes alongside clinical measures is crucial for optimal JIA care.
Area of Science:
- Pediatric Rheumatology
- Clinical Outcome Measurement
- Chronic Childhood Illness
Background:
- Juvenile idiopathic arthritis (JIA) significantly impacts children's quality of life due to disease and treatment-related morbidity.
- Optimizing JIA management requires effective monitoring of disease activity and treatment efficacy.
- International pediatric rheumatology societies have developed validated measures for assessing JIA activity.
Purpose of the Study:
- To review and describe the primary outcome measures used for assessing disease activity in Juvenile Idiopathic Arthritis (JIA) patients.
- To highlight the importance of standardized tools in monitoring JIA progression and treatment response.
- To discuss the evolving landscape of outcome measures, including patient-reported outcomes.
Main Methods:
- A literature review was conducted to identify and describe current outcome measures for JIA disease activity.
- Analysis focused on validated tools endorsed by professional pediatric rheumatology societies.
- The review considered both clinical and patient-reported outcome measures.
Main Results:
- The Juvenile Disease Activity Score (JADAS), including its variants (JADAS-CRP, cJADAS), is a key tool for assessing disease activity and treatment response in JIA.
- Validated definitions of disease activity and treatment response facilitate a treat-to-target strategy for tight JIA control.
- There is a growing emphasis on incorporating patient-reported or parent-reported outcomes (PRCOs) in JIA assessment.
Conclusions:
- Clinical outcome measures are essential for effective Juvenile Idiopathic Arthritis (JIA) patient care.
- The use of JADAS and validated response criteria supports a structured, target-driven approach to JIA management.
- Further research and integration of patient-reported outcomes are needed for comprehensive JIA care.
Abstract:
Juvenile idiopathic arthritis (JIA), as a chronic condition, is associated with significant disease- and treatment-related morbidity, thus impacting children's quality of life. In order to optimize JIA management, the paediatric rheumatologist has begun to regularly use measurements of disease activity developed, validated and endorsed by international paediatric rheumatology professional societies in an effort to monitor the disease course over time and assess the efficacy of therapeutic interventions in JIA patients.A literature review was performed to describe the main outcome measures currently used in JIA patients to determine disease activity status.The Juvenile Disease Activity Score (JADAS), in its different versions (classic JADAS, JADAS-CRP and cJADAS) and the validated definitions of disease activity and response to treatment represent an important tool for the assessment of clinically relevant changes in disease activity, leading more and more to a treat-to-target strategy, based on a tight and thorough control of the patient condition. Moreover, in recent years, increasing attention on the incorporation of patient-reported or parent-reported outcomes (PRCOs), when measuring the health state of patients with paediatric rheumatic diseases has emerged.We think that the care of JIA patients cannot be possible without taking into account clinical outcome measures and, in this regard, further work is required.
More Related Videos
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
01:19Pericarditis II: Clinical Features and Diagnostic Tests